Brandi G.; Relli V.; Deserti M.; Palloni A.; Indio V.; Astolfi A.; Serravalle S.; Mattiaccio A.; Vasuri F.; Malvi D.; Deiana C.; Pantaleo M.A.; Cescon M.; Rizzo A.; Katoh M.; Tavolari S., Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies, «SCIENTIFIC REPORTS», 2024, 14, Article number: 3136 , pp. 1 - 10 [Scientific article]Open Access
Brandi G.; Deiana C.; Galvani L.; Palloni A.; Ricci A.D.; Rizzo A.; Tavolari S., Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue, «FRONTIERS IN ONCOLOGY», 2023, 13, Article number: 1137510 , pp. 1 - 10 [Scientific article]Open Access
Vasuri, Francesco; Deserti, Marzia; Corradini, Angelo G; Tavolari, Simona; Relli, Valeria; Palloni, Andrea; Frega, Giorgio; Curti, Stefania; Mattioli, Stefano; Cescon, Matteo; D'Errico, Antonia; Brandi, Giovanni, Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot study, «SCIENTIFIC REPORTS», 2023, 13, Article number: 2580 , pp. 1 - 7 [Scientific article]Open Access
Brandi G.; Tovoli F.; Tavolari S., Have We Found the “Holy Grail” That May Predict Response to Immunotherapy in Hepatocellular Carcinoma?, «GASTROENTEROLOGY», 2023, 164, pp. 15 - 18 [Scientific article]
Tavolari S.; Brandi G., Mutational Landscape of Cholangiocarcinoma According to Different Etiologies: A Review, «CELLS», 2023, 12, Article number: 1216 , pp. 1 - 14 [Scientific article]Open Access
Brandi, Giovanni; Straif, Kurt; Mandrioli, Daniele; Curti, Stefania; Mattioli, Stefano; Tavolari, Simona, Exposure to Asbestos and Increased Intrahepatic Cholangiocarcinoma Risk: Growing Evidences of a Putative Causal Link, «ANNALS OF GLOBAL HEALTH», 2022, 88, Article number: 41 , pp. 1 - 6 [Scientific article]Open Access
Di Federico A.; Mosca M.; Pagani R.; Carloni R.; Frega G.; De Giglio A.; Rizzo A.; Ricci D.; Tavolari S.; Di Marco M.; Palloni A.; Brandi G., Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes, «CANCERS», 2022, 14, Article number: 2429 , pp. 1 - 14 [Scientific article]Open Access
Alessandro Di Federico, Mirta Mosca, Rachele Pagani, Riccardo Carloni, Giorgio Frega, Andrea De Giglio, Alessandro Rizzo, Dalia Ricci, Simona Tavolari, Mariacristina Di Marco, Andrea Palloni, Giovanni Brandi., Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumour Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes, «CANCERS», 2022, 14, Article number: 2429 , pp. 1 - 14 [Scientific article]Open Access
Rizzo, A.; Frega, G.; Palloni, A.; Piemontese, A.; Di Federico, A.; Ricci, A.; Carloni, R.; Fabbri, F.; Novelli, M.; Tavolari, S.; Di Marco, M.; Ravaioli, M.; Brandi, G., Intensive follow-up program and oncological outcomes of 278 biliary tract cancer patients after curative intent surgery: A single-center retrospective experience, «ANNALS OF ONCOLOGY», 2021, 32, Article number: P-69 , pp. S120 - S120 [Scientific article]
Di Federico A.; Rizzo A.; Ricci A.D.; Frega G.; Palloni A.; Tavolari S.; Brandi G., Nivolumab: an investigational agent for the treatment of biliary tract cancer, «EXPERT OPINION ON INVESTIGATIONAL DRUGS», 2021, 30, pp. 325 - 332 [Scientific article]
Rizzo A.; Frega G.; Ricci A.D.; Palloni A.; Abbati F.; de Lorenzo S.; Deserti M.; Tavolari S.; Brandi G., Anti-EGFR monoclonal antibodies in advanced biliary tract cancer: A systematic review and meta-analysis, «IN VIVO», 2020, 34, pp. 479 - 488 [Scientific article]
Brandi G.; Tavolari S., Asbestos and Intrahepatic Cholangiocarcinoma, «CELLS», 2020, 9, Article number: 421 , pp. 1 - 15 [Scientific article]Open Access
Rizzo A.; Ricci A.D.; Tavolari S.; Brandi G., Circulating tumor DNA in biliary tract cancer: Current evidence and future perspectives, «CANCER GENOMICS & PROTEOMICS.», 2020, 17, pp. 441 - 452 [Scientific article]
Marin J.J.G.; Prete M.G.; Lamarca A.; Tavolari S.; Landa-Magdalena A.; Brandi G.; Segatto O.; Vogel A.; Macias R.I.R.; Rodrigues P.M.; Casta A.L.; Mertens J.; Rodrigues C.M.P.; Fernandez-Barrena M.G.; Da Silva Ruivo A.; Marzioni M.; Mentrasti G.; Acedo P.; Munoz-Garrido P.; Cardinale V.; Banales J.M.; Valle J.W.; Bridgewater J.; Braconi C., Current and novel therapeutic opportunities for systemic therapy in biliary cancer, «BRITISH JOURNAL OF CANCER», 2020, 123, pp. 1047 - 1059 [Scientific article]
Massa A.; Varamo C.; Vita F.; Tavolari S.; Peraldo-Neia C.; Brandi G.; Rizzo A.; Cavalloni G.; Aglietta M., Evolution of the experimental models of cholangiocarcinoma, «CANCERS», 2020, 12, Article number: 2308 , pp. 1 - 31 [Scientific article]Open Access
